Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals

被引：0
|
作者：
Kathryn J. Eagye
David P. Nicolau
机构：
[1] Hartford Hospital,Center for Anti
[2] Hartford Hospital,Infective Research and Development
[3] Hartford Hospital,Center for Anti
来源：
Advances in Therapy | 2011年 / 28卷
关键词：
antimicrobial resistance; fluoroquinolones; imipenem;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：326 / 333
页数：7
相关论文
共 50 条
  • [31] Class 1 integron and Imipenem Resistance in Clinical Isolates of Pseudomonas aeruginosa: Prevalence and Antibiotic Susceptibility
    Yousefi
    Nahaei, M. R.
    Farajnia, S.
    Ghojazadeh, M.
    Akhi, M. T.
    Sharifi, Y.
    Milani, M.
    Ghotaslou, R.
    IRANIAN JOURNAL OF MICROBIOLOGY, 2010, 2 (03) : 113 - 119
  • [32] Susceptibility of pseudomonas aeruginosa to doripenem and imipenem in the united states: 2006-2007 trust surveillance
    Draghi, Deborah C.
    Brown, Nina P.
    Pillar, Chris
    Sahm, Daniel F.
    Yee, Cheung
    Evangelista, Alan T.
    CRITICAL CARE MEDICINE, 2007, 35 (12) : A251 - A251
  • [33] Management of fluoroquinolone resistance in Pseudomonas aeruginosa - Outcome of monitored use in a referral hospital
    Peterson, LR
    Postelnick, M
    Pozdol, TL
    Reisberg, B
    Noskin, GA
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1998, 10 (03) : 207 - 214
  • [34] Reduction in Fluoroquinolone Use following Introduction of Ertapenem into a Hospital Formulary Is Associated with Improvement in Susceptibility of Pseudomonas aeruginosa to Group 2 Carbapenems: a 10-Year Study
    Cook, Paul P.
    Gooch, Michael
    Rizzo, Shemra
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (12) : 5597 - 5601
  • [35] Fluoroquinolone susceptibility in Pseudomonas aeruginosa isolates from dogs - comparing disk diffusion and microdilution methods
    Pintaric, Selma
    Matanovic, Kresimir
    Martinec, Branka Seol
    VETERINARSKI ARHIV, 2017, 87 (03) : 291 - 300
  • [36] Isolation of Pseudomonas aeruginosa from Cockroaches Captured in Hospitals in Japan, and Their Antibiotic Susceptibility
    Saitou, Keiko
    Furuhata, Katsunori
    Kawakami, Yasushi
    Fukuyama, Masafumi
    BIOCONTROL SCIENCE, 2009, 14 (04) : 155 - 159
  • [37] Genomics and Antimicrobial Susceptibility of Clinical Pseudomonas aeruginosa Isolates from Hospitals in Brazil
    Camargo, Carlos Henrique
    Yamada, Amanda Yaeko
    de Souza, Andreia Rodrigues
    Lima, Marisa de Jesus de Castro
    Cunha, Marcos Paulo Vieira
    Ferraro, Pedro Smith Pereira
    Sacchi, Claudio Tavares
    dos Santos, Marlon Benedito Nascimento
    Campos, Karoline Rodrigues
    Tiba-Casas, Monique Ribeiro
    Freire, Maristela Pinheiro
    Barretti, Pasqual
    PATHOGENS, 2023, 12 (07):
  • [38] Imipenem, Meropenem, or Doripenem To Treat Patients with Pseudomonas aeruginosa Ventilator-Associated Pneumonia
    Luyt, Charles-Edouard
    Aubry, Alexandra
    Lu, Qin
    Micaelo, Maite
    Brechot, Nicolas
    Brossier, Florence
    Brisson, Helene
    Rouby, Jean-Jacques
    Trouillet, Jean-Louis
    Combes, Alain
    Jarlier, Vincent
    Chastre, Jean
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (03) : 1372 - 1380
  • [39] Imipenem, Meropenem Or Doripenem To Treat Patients With Pseudomonas AerugINOSa Ventilator-Associated Pneumonia
    Luyt, C-E
    Aubry, A.
    Lu, Q.
    Rouby, J.
    Combes, A.
    Jarlier, V.
    Chastre, J. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [40] Absence of Association between Use of Ertapenem and Change in Antipseudomonal Carbapenem Susceptibility Rates in 25 Hospitals
    Eagye, Kathryn J.
    Nicolau, David P.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05): : 485 - 490
12345